Peroxide, cyclohexylidenebis[(1,1-dimethylpropyl)
Common Name: |
Peroxide, cyclohexylidenebis[(1,1-dimethylpropyl) |
IUPAC Name: |
1,1-bis(2-methylbutan-2-ylperoxy)cyclohexane |
Molecular Formula: |
C16H32O4 |
SMILES: |
CCC(C)(C)OOC1(CCCCC1)OOC(C)(C)CC |
Inchi: |
1S/C16H32O4/c1-7-14(3,4)17-19-16(12-10-9-11-13-16)20-18-15(5,6)8-2/h7-13H2,1-6H3 |
Inchi Key: |
IMYCVFRTNVMHAD-UHFFFAOYSA-N |
Cas No: |
15667-10-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
288.42 |
Mass (g/mol) |
288.23 |
Molar Refractivity |
81.37 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
8 |
Rings |
1 |
TPSA |
36.92 |
Hetero Atoms |
4 |
Heavy Atoms |
20 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
4.92 |
iLOGP |
4.15 |
XLOGP3 |
4.77 |
WLOGP |
4.92 |
MLOGP |
3.43 |
ESOL Log S |
-4.11 |
ESOL Solubility (mg/ml) |
0.023 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-5.28 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.72 |
Silicos-IT Solubility (mg/ml) |
0.05 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.67 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.874 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.126 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |